Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Rhabdomyosarcoma treated with chemotherapy during the third trimester

D Martin¹, S S Winter, M O Gardner

¹Department of Obstetrics and Gynecology, School of Medicine, University of New Mexico Health Science Center, Albuquerque, USA.

Obstetrics and Gynecology

|May 1, 1997

Summary

Chemotherapy effectively treated aggressive rhabdomyosarcoma in a pregnant patient, showing no adverse fetal complications. This highlights chemotherapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

The Journal of clinical investigation·1996

Same author

Deprivation payments to general practitioners: limitations of census data.

BMJ (Clinical research ed.)·1996

Same author

Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury.

Journal of neuroscience research·1996

Same author

Visceral ischemia-reperfusion injury promotes tumor necrosis factor (TNF) and interleukin-1 (IL-1) dependent organ injury in the mouse.

Shock (Augusta, Ga.)·1996

Same author

Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.

Journal of the American College of Cardiology·1996

Same author

Leadshot: an unusual cause of stent occlusion.

Endoscopy·1996

Area of Science:

Oncology
Maternal-Fetal Medicine

Background:

Rhabdomyosarcoma is a rare and aggressive tumor during pregnancy.
Standard treatment involves multiagent chemotherapy, posing maternal-fetal risks.

Observation:

A case of stage III facial rhabdomyosarcoma in an 18-year-old pregnant woman.
Diagnosis occurred in the third trimester of pregnancy.

Findings:

The patient achieved clinical remission with multiagent chemotherapy during pregnancy.
No fetal complications were observed during or after treatment.

Implications:

Chemotherapy is a crucial frontline treatment for pregnant women with rhabdomyosarcoma.
Effective chemotherapy can lead to successful remission without compromising fetal health.

Related Experiment Videos